Vistagen Therapeutics Inc (VTGN)
3.52
0.00 (0.00%)
USD |
NASDAQ |
Jun 14, 16:00
3.39
-0.13
(-3.69%)
After-Hours: 20:00
Vistagen Therapeutics Revenue (Quarterly): 0.1973M for March 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 0.1973M |
December 31, 2023 | 0.4114M |
September 30, 2023 | 0.2777M |
June 30, 2023 | 0.1776M |
March 31, 2023 | 0.1759M |
December 31, 2022 | 0.1796M |
September 30, 2022 | -0.8925M |
June 30, 2022 | 0.3101M |
March 31, 2022 | 0.0389M |
December 31, 2021 | 0.3579M |
September 30, 2021 | 0.358M |
June 30, 2021 | 0.3541M |
March 31, 2021 | 0.4419M |
December 31, 2020 | 0.3136M |
September 30, 2020 | 0.334M |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | |
September 30, 2019 | |
June 30, 2019 | |
March 31, 2019 | |
December 31, 2018 | |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 |
Date | Value |
---|---|
December 31, 2017 | |
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | 1.25M |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | 0.2004M |
March 31, 2012 | 0.4689M |
December 31, 2011 | 0.0024M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
-0.8925M
Minimum
Sep 2022
0.4419M
Maximum
Mar 2021
0.2024M
Average
0.3101M
Median
Jun 2022
Revenue (Quarterly) Benchmarks
Axsome Therapeutics Inc | 75.00M |
NovaBay Pharmaceuticals Inc | 2.631M |
Palatin Technologies Inc | -- |
iBio Inc | -- |
Theriva Biologics Inc | -- |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | -9.521M |
Total Expenses (Quarterly) | 11.56M |
EPS Diluted (Quarterly) | -0.3523 |
Enterprise Value | -24.04M |
Profit Margin (Quarterly) | -4.83K% |
Earnings Yield | -61.71% |
Normalized Earnings Yield | -61.71 |